Dr Deborah Dewar

- Senior Lecturer (Stroke and Brain Imaging)
telephone: 01413305828
email: Deborah.Dewar@glasgow.ac.uk
Debbie Dewar is a neuroscientist with a B.Sc. in Biology & Psychology from Edinburgh University and a PhD from the Institute of Psychiatry, London. She has a long-standing interest in how brain chemistry and structure are altered after acute brain injury and in chronic brain disorders with a view to understanding pathogenic mechanisms and identifying targets for therapeutic intervention. Brain imaging at a variety of different levels, from tissue sections to whole brain is used in the majority of her research.
Developing novel treatments for reducing brain damage after a stroke is a major focus of current research. This work uses experimental models of cerebral ischaemia and insulin resistance in combination with various imaging techniques including, MRI, quantitative histology, immunohistochemistry and autoradiographic measurement of cerebral blood flow to understand how hyperglycaemia caused by either brain injury-induced stress or existing insulin resistance influences the extent of brain damage.
Figure shows MRI of rat brain slices following induction of focal cerebral ischaemia. The perfusion deficit is indicated in red and the diffusion lesion indicated in white. The mismatch between the two regions indicates the tissue that is “at risk” but may be protected from irreversible damage by intervention. Current work is aimed at determining if this area is compromised in the insulin resistant state. Images generated by PhD student David Tarr in collaboration with the Glasgow Experimental MRI Centre.
Previous research into neurotransmitter deficits in human postmortem brain from patients with Alzheimer’s disease or traumatic brain injury lead to current research developing novel molecular neuroimaging radiotracers for Single Photon Emission Tomography (SPECT). This work is done in collaboration with Sally Pimlott (NHS Radiopharmaceutical Research & Development) and Andy Sutherland (School of Chemistry). Current research is focussed on molecules that could be used to image the brain noradrenaline transporter or the translocator protein (as a biomarker of activated microglia after traumatic brain injury; collaboration with Willie Stewart, Department of Neuropathology, Institute of Neurological Sciences).
Image shows a whole body dynamic planar image obtained after intravenous injection of the noradrenaline transporter ligand ¹²³I-NKJ64. Image generated by PhD student Adriana Tavares.
- Visualisation of activated microglia in traumatic brain injury: an in vitro autoradiography study in human post-mortem brain tissue
NHS Greater Glasgow & Clyde, Endowment Funds Office
2010 - 2011
- Visualisation of activated microglia in traumatic brain injury: an in vitro autoradiography study in human post-mortem brain tissue
NHS Greater Glasgow & Clyde, Endowment Funds Office
2010 - 2011
- Metabolic syndrome, hyperglycemia and experimental stroke
Scottish Executive Health Department
2009 - 2010
- Experimental validation by micro-SPECT of two different radioligands for imaging serotin transporter density
Neurosciences Foundation
2007 - 2008
- Evaluation of antiepileptic drug action using in vivo micro-SPECT imaging
Epilepsy Research Foundation
2006 - 2007
- A Pilot Study to Optimise High Resolution Magnetic Resonance Microscopy Imaging of fixed brain tissue from modified mice
Neurosciences Foundation
2006 - 2006
- Development of a molecular imaging tracer for the noradrenaline transporter
Scottish Hospital Endowments Research Trust
2006 - 2008
- Image analysis equipment for neurotransmitter autoradiography
Tenovus-Scotland
2006 - 2006
- The use of olfactory epithelial stem cells for CNS repair
MRC
2004 - 2007
